October 21, 2016 12:40 PM ET


Company Overview of Angiogenix, Inc.

Company Overview

Angiogenix, Inc., a biopharmaceutical company, develops therapeutic solutions for chronic vascular disease. Its products include ACCLAIM, a treatment for chronic ischemia; ANGX-1039, a peripheral vascular disease drug therapy for peripheral blood flow; ANGX-3227, a treatment for sickle cell disease; and Vasotrophin, a product for the generation of blood vessels. The company serves cardiovascular disease, peripheral vascular disease, and sickle cell disease markets. Angiogenix, Inc. was founded in 1997 and is headquartered in Burlingame, California.

500 Airport Boulevard

Suite 100

Burlingame, CA 94010

United States

Founded in 1997





Key Executives for Angiogenix, Inc.

Chief Executive Officer and Director
Age: 69
Vice President of Finance and Chief Financial Officer
Age: 69
Vice President of Business Development
Vice President of Pharmaceutical Development
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Angiogenix, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.